Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends. | Viruses | 2024 | 39205305 | PubTator, text mining | PubMed |
| Characterization of viroplasm-like structures by co-expression of NSP5 and NSP2 across rotavirus species A to J. | J Virol | 2024 | 39194242 | PubTator, text mining | PubMed |
| An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease. | Microbiol Spectr | 2024 | 39162260 | PubTator, text mining | PubMed |
| Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana. | Open Forum Infect Dis | 2024 | 39015352 | PubTator, text mining | PubMed |
| How does a Saccharomyces cerevisiae extract influence the components of isolated rotavirus particles from stool samples collected in a clinical setting from children? | Saudi J Biol Sci | 2024 | 38946847 | PubTator, text mining | PubMed |
| Emergence of a Novel G4P[6] Porcine Rotavirus with Unique Sequence Duplication in NSP5 Gene in China. | Animals (Basel) | 2024 | 38929409 | PubTator, text mining | PubMed |
| Mutation prediction in the SARS-CoV-2 genome using attention-based neural machine translation. | Math Biosci Eng | 2024 | 38872567 | PubTator, text mining | PubMed |
| Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease. | Elife | 2024 | 38814682 | PubTator, text mining | PubMed |
| The Role of the Host Cytoskeleton in the Formation and Dynamics of Rotavirus Viroplasms. | Viruses | 2024 | 38793550 | PubTator, text mining | PubMed |
| Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform. | J Biol Chem | 2024 | 38750796 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2. | J Cell Sci | 2024 | 38682259 | PubTator, text mining | PubMed |
| Evaluation of different genomic regions of rotavirus B and rotavirus C for development of real-time RT‒PCR assays. | Virol J | 2024 | 38659036 | PubTator, text mining | PubMed |
| Swine acute diarrhea syndrome coronavirus Nsp1 suppresses IFN-λ1 production by degrading IRF1 via ubiquitin-proteasome pathway. | Vet Res | 2024 | 38589958 | PubTator, text mining | PubMed |
| Editorial: Immunological aspects of emerging and re-emerging zoonoses. | Front Immunol | 2024 | 38510255 | PubTator, text mining | PubMed |
| The recruitment of TRiC chaperonin in rotavirus viroplasms correlates with virus replication. | mBio | 2024 | 38470055 | PubTator, text mining | PubMed |
| Ubiquitin Ligase Parkin Regulates the Stability of SARS-CoV-2 Main Protease and Suppresses Viral Replication. | ACS Infect Dis | 2024 | 38386664 | PubTator, text mining | PubMed |
Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of Breast Cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway. | Clin Breast Cancer | 2024 | 38341369 | PubTator, text mining | PubMed |
| Convergence and equilibrium in molecular dynamics simulations. | Commun Chem | 2024 | 38326482 | PubTator, text mining | PubMed |
| Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants. | J Immunol Res | 2024 | 38304142 | PubTator, text mining | PubMed |
| Recent advances in chemometric modelling of inhibitors against SARS-CoV-2. | Heliyon | 2024 | 38293468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=8